ArticleBMC cancer2018

Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report.

Nuno Cerveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.